Rhenman & Partners Asset Management AB - Q3 2023 holdings

$928 Million is the total value of Rhenman & Partners Asset Management AB's 85 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 7.2% .

 Value Shares↓ Weighting
LLY BuyLILLY ELI & CO$53,713,000
+41.4%
100,000
+23.5%
5.79%
+44.6%
BSX BuyBOSTON SCIENTIFIC CORP$36,960,000
+17.8%
700,000
+20.7%
3.98%
+20.5%
BMRN  BIOMARIN PHARMACEUTICAL INC$33,622,400
+2.1%
380,0000.0%3.62%
+4.4%
REGN BuyREGENERON PHARMACEUTICALS$32,918,400
+30.9%
40,000
+14.3%
3.55%
+33.9%
MCK  MCKESSON CORP$30,874,350
+1.8%
71,0000.0%3.33%
+4.1%
MDT BuyMEDTRONIC PLC$29,385,000
+14.2%
375,000
+28.4%
3.17%
+16.8%
VRTX BuyVERTEX PHARMACEUTICALS INC$26,602,110
+19.0%
76,500
+20.5%
2.87%
+21.7%
ABT BuyABBOTT LABS$25,343,224
-6.6%
261,675
+5.1%
2.73%
-4.5%
BDX  BECTON DICKINSON & CO$24,560,350
-2.1%
95,0000.0%2.65%
+0.2%
HUM BuyHUMANA INC$23,839,480
+15.9%
49,000
+6.5%
2.57%
+18.5%
UNH SellUNITED HEALTH GROUP INC$23,192,740
-19.6%
46,000
-23.3%
2.50%
-17.7%
CI SellCIGNA CORP NEW$22,885,600
-29.1%
80,000
-30.4%
2.47%
-27.5%
ABBV  ABBVIE INC$22,359,000
+10.6%
150,0000.0%2.41%
+13.2%
THC BuyTENET HEALTHCARE CORP$22,073,150
-6.5%
335,000
+15.5%
2.38%
-4.3%
ABC  CENCORA INC$21,416,430
-6.5%
119,0000.0%2.31%
-4.3%
CVS BuyCVS HEALTH CORP$20,946,000
+22.2%
300,000
+21.0%
2.26%
+25.0%
HCA BuyHCA HEALTHCARE INC$20,416,340
+4.3%
83,000
+28.7%
2.20%
+6.7%
ISRG BuyINTUITIVE SURGICAL INC$19,729,575
+31.1%
67,500
+53.4%
2.13%
+34.1%
MRK  MERCK & CO. INC$19,560,500
-10.8%
190,0000.0%2.11%
-8.7%
COO BuyCOOPER COS INC$19,065,000
-5.8%
60,000
+13.6%
2.06%
-3.7%
JAZZ SellJAZZ PHARMACEUTICALS PLC$18,591,985
+3.4%
143,634
-0.9%
2.00%
+5.8%
GILD  GILEAD SCIENCES INC$17,535,960
-2.8%
234,0000.0%1.89%
-0.5%
ANTM SellELEVANCE HEALTH INC$16,545,960
-33.5%
38,000
-32.1%
1.78%
-32.0%
BuyPROCEPT BIOROBOTICS CORP$16,175,330
+64.0%
493,000
+76.7%
1.74%
+67.7%
SWAV BuySHOCKWAVE MEDICAL INC$16,127,100
+0.9%
81,000
+44.6%
1.74%
+3.2%
DHR  DANAHER CORPORATION$14,886,000
+3.4%
60,0000.0%1.60%
+5.7%
BIIB SellBIOGEN INC$14,521,065
-21.0%
56,500
-12.4%
1.57%
-19.2%
AXNX  AXONICS INC$12,907,600
+11.2%
230,0000.0%1.39%
+13.7%
NTRA BuyNATERA INC$11,804,528
+21.3%
266,769
+33.4%
1.27%
+24.1%
LNTH BuyLANTHEUS HLDGS INC$11,672,640
+39.1%
168,000
+68.0%
1.26%
+42.1%
IMGN SellIMMUNOGEN INC$11,109,000
-21.5%
700,000
-6.7%
1.20%
-19.7%
EXAS SellEXACT SCIENCES CORP$10,915,200
-33.6%
160,000
-8.6%
1.18%
-32.0%
PRVA  PRIVIA HEALTH GROUP INC$10,580,000
-11.9%
460,0000.0%1.14%
-9.9%
ALKS BuyALKERMES PLC$10,363,700
-5.4%
370,000
+5.7%
1.12%
-3.3%
DVAX  DYNAVAX TECHNOLOGIES CORP$10,339,000
+14.3%
700,0000.0%1.12%
+17.0%
IQV  IQVIA HLDGS INC$9,247,250
-12.5%
47,0000.0%1.00%
-10.5%
CRL NewCHARLES RIV LABS INTL INC$8,623,12044,000
+100.0%
0.93%
ALHC BuyALIGNMENT HEALTHCARE INC$8,328,000
+44.8%
1,200,000
+20.0%
0.90%
+48.2%
APLS BuyAPELLIS PHARMACEUTICALS INC$8,178,600
-52.7%
215,000
+13.2%
0.88%
-51.7%
ALNY  ALNYLAM PHARMACEUTICALS INC$7,969,500
-6.8%
45,0000.0%0.86%
-4.7%
MRTX BuyMIRATI THERAPEUTICS INC$7,623,000
+50.7%
175,000
+25.0%
0.82%
+54.2%
ZBH SellZIMMER BIOMET HOLDINGS INC$6,733,200
-66.5%
60,000
-56.5%
0.73%
-65.7%
IMVT BuyIMMUNOVANT INC$6,375,082
+236.1%
166,061
+66.1%
0.69%
+243.5%
NBIX BuyNEUROCRINE BIOSCIENCES INC$6,138,675
+62.7%
54,566
+36.4%
0.66%
+66.3%
KRTX  KARUNA THERAPEUTICS INC$5,918,150
-22.0%
35,0000.0%0.64%
-20.2%
CYTK  CYTOKINETICS INC$5,892,000
-9.7%
200,0000.0%0.64%
-7.7%
BNTX SellBIONTECH SEsponsored ads$5,757,920
-23.8%
53,000
-24.3%
0.62%
-22.0%
GKOS SellGLAUKOS CORP$5,493,250
-18.8%
73,000
-23.2%
0.59%
-17.0%
ITCI  INTRA-CELLULAR THERAPIES INC$4,948,550
-17.7%
95,0000.0%0.53%
-15.8%
VEEV SellVEEVA SYS INC$4,679,350
-32.4%
23,000
-34.3%
0.50%
-30.7%
IMCR  IMMUNOCORE HLDGS PLCads$4,633,528
-13.4%
89,2780.0%0.50%
-11.3%
XNCR  XENCOR INC$4,533,750
-19.3%
225,0000.0%0.49%
-17.4%
 R1 RCM INC$4,521,000
-18.3%
300,0000.0%0.49%
-16.5%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$4,322,500
-27.8%
950,000
+11.8%
0.47%
-26.1%
OSCR NewOSCAR HEALTH INCcl a$4,288,900770,000
+100.0%
0.46%
DXCM NewDEXCOM INC$4,198,50045,000
+100.0%
0.45%
RVNC BuyREVANCE THERAPEUTICS INC$4,148,458
+33.3%
361,679
+194.0%
0.45%
+36.3%
RPRX  ROYALTY PHARMA PLC$4,071,000
-11.7%
150,0000.0%0.44%
-9.7%
 NUVALENT INC$3,953,926
+9.0%
86,0110.0%0.43%
+11.5%
EVH  EVOLENT HEALTH INCcl a$3,948,350
-10.1%
145,0000.0%0.43%
-8.0%
BBIO  BRIDGEBIO PHARMA INC$3,559,950
+53.3%
135,0000.0%0.38%
+56.7%
WST  WEST PHARMACEUTICAL SVSC INC$3,376,890
-1.9%
9,0000.0%0.36%
+0.3%
HCAT  HEALTH CATALYST INC$3,238,400
-19.0%
320,0000.0%0.35%
-17.3%
MRNA SellMODERNA INC$3,098,700
-43.3%
30,000
-33.3%
0.33%
-42.0%
TECH SellBIO-TECHNE CORP$2,905,228
-25.1%
42,680
-10.1%
0.31%
-23.5%
AXSM  AXSOME THERAPEUTICS INC$2,802,589
-2.7%
40,1000.0%0.30%
-0.7%
TXG Sell10X GENOMICS INC$2,805,000
-63.1%
68,000
-50.0%
0.30%
-62.3%
HRMY SellHARMONY BIOSCIENCES HLDGS IN$2,669,903
-63.9%
81,474
-61.2%
0.29%
-63.0%
MGTX  MEIRAGTX HLDGS PLC$2,646,421
-26.9%
538,9860.0%0.28%
-25.4%
OLK  OLINK HLDG ABsponsored ads$2,448,500
-21.3%
166,0000.0%0.26%
-19.5%
CNC NewCENTENE CORP DEL$2,066,40030,000
+100.0%
0.22%
EW  EDWARDS LIFESCIENCES CORP$2,009,120
-26.6%
29,0000.0%0.22%
-24.7%
VKTX  VIKING THERAPEUTICS INC$1,992,600
-31.7%
180,0000.0%0.22%
-30.2%
IGMS  IGM BIOSCIENCES INC$1,670,000
-9.5%
200,0000.0%0.18%
-7.7%
ARVN  ARVINAS INC$1,669,400
-20.9%
85,0000.0%0.18%
-18.9%
RLAY  RELAY THERAPEUTICS INC$1,597,900
-33.0%
190,0000.0%0.17%
-31.7%
NTLA  INTELLIA THERAPEUTICS INC$1,581,000
-22.5%
50,0000.0%0.17%
-20.9%
INSP SellINSPIRE MED SYS INC$1,389,080
-72.2%
7,000
-54.5%
0.15%
-71.5%
TGTX BuyTG THERAPEUTICS INC$1,337,600
-2.1%
160,000
+190.9%
0.14%0.0%
INMB  INMUNE BIO INC$1,219,463
-24.7%
178,2840.0%0.13%
-23.4%
EPIX  ESSA PHARMA INC$1,101,585
+14.4%
356,5000.0%0.12%
+17.8%
ALLO  ALLOGENE THERAPEUTICS INC$951,000
-36.2%
300,0000.0%0.10%
-34.4%
OM SellOUTSET MED INC$544,000
-92.5%
50,000
-84.9%
0.06%
-92.3%
MRSN  MERSANA THERAPEUTICS INC$508,000
-61.4%
400,0000.0%0.06%
-60.4%
TMO  THERMO FISHER SCIENTIFIC INC$253,085
-3.0%
5000.0%0.03%0.0%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-253,832
-100.0%
-0.04%
MOH ExitMOLINA HEALTHCARE INC$0-21,700
-100.0%
-0.69%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Rhenman & Partners Asset Management AB's holdings